Saturday, April 9, 2011

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

Posted by https://www.med-chemist.com at 11:13 AM
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)